Does the non-adjunctive indication for CGM-based treatment decisions apply to Dexcom CGM-integrated insulin pumps?

You are here

No, patients should not make CGM-based treatment decisions using the Animas and Tandem insulin pumps that are integrated with Dexcom CGM. These integrated pump systems are not currently approved for non-adjunctive use. Patients on insulin pump therapy would need to use the standalone Dexcom G5 Mobile (including the G5 Transmitter) to make treatment decisions.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.